Over the past few years, I’ve watched a major shift take shape in medical device manufacturing. More and more companies are rethinking where and how they produce their products. For a long time, overseas manufacturing was the default. Today, OEMs are increasingly seeking more control, less risk, and faster paths from concept to customer. Near-shoring answers that need.

At Life Science Outsourcing, we support diagnostic innovators through compliant, end-to-end solutions in reagent packaging, contamination control, and manufacturing scale-up—so they can stay focused on advancing healthcare. 

Renting cleanroom space offers medical device startups and OEMs faster market entry, lower capital risk, and built-in regulatory compliance. This diagnostic helps companies evaluate whether renting or building aligns better with their stage, resources, and long-term plans—while highlighting how LSO supports both models with scalable, validated facilities.